These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

118 related items for PubMed ID: 11357488

  • 41. Plasma renin and prorenin and renin gene variation in patients with insulin-dependent diabetes mellitus and nephropathy.
    Deinum J, Tarnow L, van Gool JM, de Bruin RA, Derkx FH, Schalekamp MA, Parving HH.
    Nephrol Dial Transplant; 1999 Aug; 14(8):1904-11. PubMed ID: 10462269
    [Abstract] [Full Text] [Related]

  • 42. Oral contraceptives, angiotensin-dependent renal vasoconstriction, and risk of diabetic nephropathy.
    Ahmed SB, Hovind P, Parving HH, Rossing P, Price DA, Laffel LM, Lansang MC, Stevanovic R, Fisher ND, Hollenberg NK.
    Diabetes Care; 2005 Aug; 28(8):1988-94. PubMed ID: 16043743
    [Abstract] [Full Text] [Related]

  • 43. [Concept and epidemiology of diabetic nephropathy].
    Tomino Y, Tanimoto M.
    Nihon Rinsho; 2005 Jun; 63 Suppl 6():309-13. PubMed ID: 15999725
    [No Abstract] [Full Text] [Related]

  • 44. [Polymorphism of aldose reductase gene and susceptibility to retinopathy and nephropathy in Caucasians with type 1 diabetes].
    Fanelli A, Hadjadj S, Gallois Y, Fumeron F, Betoule D, Grandchamp B, Marre M.
    Arch Mal Coeur Vaiss; 2002 Jun; 95(7-8):701-8. PubMed ID: 12365083
    [Abstract] [Full Text] [Related]

  • 45. The relationship between glucose control and the development of diabetic nephropathy in type I diabetes.
    Molitch ME.
    Semin Nephrol; 1997 Mar; 17(2):101-13. PubMed ID: 9148376
    [Abstract] [Full Text] [Related]

  • 46. [Nephropathy in type 1 diabetes mellitus. Current experimental and clinical aspects].
    Teschner M, Schaefer RM, Bahner U, Heidland A.
    Dtsch Med Wochenschr; 1992 Nov 06; 117(45):1730-4. PubMed ID: 1425285
    [No Abstract] [Full Text] [Related]

  • 47. Polymorphisms in the gene encoding angiotensin I converting enzyme 2 and diabetic nephropathy.
    Fröjdö S, Sjölind L, Parkkonen M, Mäkinen VP, Kilpikari R, Pettersson-Fernholm K, Forsblom C, Fagerudd J, Tikellis C, Cooper ME, Wessman M, Groop PH, FinnDiane Study Group.
    Diabetologia; 2005 Nov 06; 48(11):2278-81. PubMed ID: 16211375
    [Abstract] [Full Text] [Related]

  • 48. [The role of genetic studies in finding the etiopathogenesis of diabetes mellitus].
    Sieradzki J.
    Przegl Lek; 2000 Nov 06; 57 Suppl 3():3-6. PubMed ID: 11293231
    [Abstract] [Full Text] [Related]

  • 49. Risk of advanced diabetic nephropathy in type 1 diabetes is associated with endothelial nitric oxide synthase gene polymorphism.
    Zanchi A, Moczulski DK, Hanna LS, Wantman M, Warram JH, Krolewski AS.
    Kidney Int; 2000 Feb 06; 57(2):405-13. PubMed ID: 10652017
    [Abstract] [Full Text] [Related]

  • 50. Pathogenesis, prevention, and treatment of diabetic nephropathy.
    Cooper ME.
    Lancet; 1998 Jul 18; 352(9123):213-9. PubMed ID: 9683226
    [Abstract] [Full Text] [Related]

  • 51. Polymorphism of catalase gene promoter in Romanian patients with diabetic kidney disease and type 1 diabetes.
    Panduru NM, Moţa E, Moţa M, Cimponeriu D, Serafinceanu C, Cheţa DM.
    Rom J Intern Med; 2010 Jul 18; 48(1):81-8. PubMed ID: 21180245
    [Abstract] [Full Text] [Related]

  • 52. Genetic predisposition to diabetic nephropathy. Evidence for a role of the angiotensin I--converting enzyme gene.
    Doria A, Warram JH, Krolewski AS.
    Diabetes; 1994 May 18; 43(5):690-5. PubMed ID: 7909524
    [Abstract] [Full Text] [Related]

  • 53. High levels of circulating TNFR1 increase the risk of all-cause mortality and progression of renal disease in type 2 diabetic nephropathy.
    Fernández-Juárez G, Villacorta Perez J, Luño Fernández JL, Martinez-Martinez E, Cachofeiro V, Barrio Lucia V, Tato Ribera AM, Mendez Abreu A, Cordon A, Oliva Dominguez JA, Praga Terente M.
    Nephrology (Carlton); 2017 May 18; 22(5):354-360. PubMed ID: 27003829
    [Abstract] [Full Text] [Related]

  • 54. Association between high von willebrand factor levels and the Thr789Ala vWF gene polymorphism but not with nephropathy in type I diabetes. The GENEDIAB Study Group and the DESIR Study Group.
    Lacquemant C, Gaucher C, Delorme C, Chatellier G, Gallois Y, Rodier M, Passa P, Balkau B, Mazurier C, Marre M, Froguel P.
    Kidney Int; 2000 Apr 18; 57(4):1437-43. PubMed ID: 10760079
    [Abstract] [Full Text] [Related]

  • 55. The influence of the ACE ( I/D) polymorphism on systemic and renal vascular responses to angiotensins in normotensive, normoalbuminuric Type 1 diabetes mellitus.
    Luik PT, Hoogenberg K, Kerstens MN, Beusekamp BJ, De Jong PE, Dullaart RP, Navis GJ.
    Diabetologia; 2003 Aug 18; 46(8):1131-9. PubMed ID: 12856080
    [Abstract] [Full Text] [Related]

  • 56. Angiotensin II and its receptors in the diabetic kidney.
    Burns KD.
    Am J Kidney Dis; 2000 Sep 18; 36(3):449-67. PubMed ID: 10977776
    [Abstract] [Full Text] [Related]

  • 57. Lack of association between the insertion/deletion polymorphism of the angiotensin-converting-enzyme gene and diabetic nephropathy in IDDM patients.
    Pfohl M, Frost D, Koch M, Clemens P, Patzies A, Schmülling RM, Beischer W, Häring HU.
    Horm Metab Res; 1998 May 18; 30(5):276-80. PubMed ID: 9660089
    [Abstract] [Full Text] [Related]

  • 58. Sex-dependent differences in renal angiotensinogen as an early marker of diabetic nephropathy.
    de Alencar Franco Costa D, Todiras M, Campos LA, Cipolla-Neto J, Bader M, Baltatu OC.
    Acta Physiol (Oxf); 2015 Mar 18; 213(3):740-6. PubMed ID: 25529203
    [Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60. [Relationship between I/D polymorphism of angiotensin I converting enzyme gene and microvascular complications in type 2 diabetic patients].
    Moleda P, Majkowska L, Safranow K, Adler G, Goracy I.
    Przegl Lek; 2007 Mar 18; 64(3):134-9. PubMed ID: 17941464
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.